Strides arm receives EIR for its US facility

The facility is one of the very few manufacturing facilities in the US with a soft gel capsule (SGC) manufacturing suite for formulations with containment needs, the company said. Strides has a portfolio of approved SGCs in the US and other regulated markets.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3atxoZi
via IFTTT